← Browse by Condition
Medical Condition

active refractory rheumatoid arthritis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06570798 Phase 2
Recruiting

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

Enrollment
220 pts
Location
United States, Austr...
Sponsor
Amgen
View Trial →